1. Home
  2. ANIX vs PED Comparison

ANIX vs PED Comparison

Compare ANIX & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.73

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$12.59

Market Cap

152.8M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
PED
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
152.8M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
ANIX
PED
Price
$2.73
$12.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.67
$30.00
AVG Volume (30 Days)
346.6K
28.4K
Earning Date
05-27-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
$45,751,000.00
Revenue This Year
N/A
$171.75
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.67
52 Week Low
$2.32
$0.43
52 Week High
$5.46
$18.89

Technical Indicators

Market Signals
Indicator
ANIX
PED
Relative Strength Index (RSI) 34.58 43.06
Support Level $2.37 $11.41
Resistance Level $3.09 $13.92
Average True Range (ATR) 0.17 1.16
MACD -0.03 -0.23
Stochastic Oscillator 17.74 4.79

Price Performance

Historical Comparison
ANIX
PED

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).

Share on Social Networks: